Defense for Chinese National in U.S. Fentanyl Case Proposes Testimony From China-Based Witness

Key Takeaways

• Defense seeks Shenzhen deposition from former freight partner
• Prosecution alleges Fang shipped fentanyl precursors worth millions
• Case hinges on WhatsApp messages linking Fang to DEA source
• Judge has yet to rule on deposition or trial delay
• Potential precedent for cross‑border testimony in drug trafficking trials

Pulse Analysis

The defense’s latest filing asks a Texas federal judge to allow a sworn deposition of Xincheng Wu, a former freight partner residing in Shenzhen. Wu asserts that the chemicals Fang moved were destined for cosmetic applications, a claim that could undercut the government’s narrative of intentional fentanyl trafficking. U.S. courts rarely compel testimony from witnesses outside their jurisdiction, so the motion raises complex questions about international service of process, evidentiary admissibility, and diplomatic considerations. If granted, the deposition could set a new procedural benchmark for cases that span multiple legal systems.

Fentanyl’s surge in the United States is fueled by a supply chain that begins in China’s chemical industry, passes through U.S. trans‑shipping hubs, and ends with Mexican cartels. The September 2023 seizure of 2,500 kilograms of precursor chemicals—one of the largest busts in U.S. history—highlighted how low‑value declarations and commingled parcels mask illicit shipments. Prosecutors argue that Fang’s communications with a DEA confidential source reveal a deliberate effort to move controlled substances, citing WhatsApp messages that discuss pricing of up to $35,000 per kilogram of fentanyl. The case underscores the challenges law‑enforcement faces in tracking a product that can be synthesized from legally produced compounds.

Beyond the courtroom, the case carries geopolitical weight. U.S. officials have repeatedly accused Beijing‑linked entities of subsidizing the fentanyl trade, and congressional investigations have called for tighter export controls on precursor chemicals. A ruling that permits foreign testimony could pressure Chinese authorities to cooperate more closely, while a denial might reinforce perceptions of legal impasse between the two nations. Either outcome will influence future policy debates on how to curb the flow of synthetic opioids and may shape the next wave of transnational drug‑trafficking prosecutions.